Neovasc Inc. (TSE:NVCN – Get Free Report) shares shot up 0.6% during mid-day trading on Monday . The stock traded as high as C$40.15 and last traded at C$40.15. 399 shares were traded during mid-day trading, a decline of 81% from the average session volume of 2,123 shares. The stock had previously closed at C$39.92.
Neovasc Price Performance
The firm has a 50-day moving average of C$40.15. The company has a debt-to-equity ratio of 44.86, a current ratio of 8.44 and a quick ratio of 8.04. The company has a market capitalization of C$110.81 million, a price-to-earnings ratio of -1.96 and a beta of 2.01.
Neovasc Company Profile
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina.
Featured Articles
- Five stocks we like better than Neovasc
- What is the NASDAQ Stock Exchange?
- Rocket Lab is the Right Stock for the Right Time
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- Insider Buying Explained: What Investors Need to Know
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.
